Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research funds teams studying cancer care to improve equity.
Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines funds procurers’ innovations for better cancer care.
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers supports cancer infrastructures to study diagnosis and treatment and improve access to care.
Implementation research for cancer prevention in Europe supports research collaborations adapting evidence-based prevention interventions to European health systems to reduce the cancer burden.
Phase 1 including first-in-human clinical trials supports research teams testing biomarker-guided medicines or multi-modal treatments to establish early safety and efficacy for rare cancers.
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies supports charities and agencies coordinating research to improve young cancer survivors’ well-being.